Delfino, Victoriana L.

HRN: 11-08-24  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/23/2023
CEFTRIAXONE 1G (VIAL)
04/23/2023
04/30/2023
IV
2 Grams
Q24H
CAP-MR
Waiting Final Action 
04/23/2023
AZITHROMYCIN 500MG TABLET (TAB)
04/23/2023
04/28/2023
PO
1 Tab
OD
CAP-MR
Waiting Final Action 
04/27/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
04/27/2023
05/04/2023
IV INFUSION
4.5gms LD And 2.25 Q6H
Q6H
CAP HR
Waiting Final Action 
05/01/2023
CEFTAZIDIME 1GM (VIAL)
05/01/2023
05/07/2023
IVT
500mg
Q24
CAP HR
Waiting Final Action 
05/02/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/02/2023
05/11/2023
IVT
500 Mg
Q8H
Infectious Diarrhea (Amoebiasis)
Waiting Final Action 
05/06/2023
CEFTAZIDIME 1GM (VIAL)
05/06/2023
05/13/2023
IV
1g
OD
CAP HR
Waiting Final Action 
05/06/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/06/2023
05/13/2023
IV
500mg
Q8
Amoebiasis
Waiting Final Action 
05/08/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/08/2023
05/15/2023
IV
500mg
Q6
Chronic E Coli Infcetion
Waiting Final Action 
05/12/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/12/2023
05/19/2023
IV
4.5grams
Q8H
CAP HR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: